Merck & Company, Inc. · NYSE:MRK
Merck & — Investor Day (2019)
7 slides from Merck &'s investor day presentation, 2019
Slide 1: Welcome & Introductions agenda
Welcome & Introductions Ken Frazier, Chairman and Chief Executive Officer Financial & Value Creation Overview Rob Davis, Chief Financial Officer and Head of Global Services Commercial Growth Drivers: KEYTRUDA & Beyond Frank Clyburn, Chief Commercial Officer Animal Health Innovation Rick DeLuca, Pres
Slide 2: Forward-Looking Statement of Merck & Co., Inc.
FORWARD-LOOKING STATEMENT OF MERCK & Co., Inc., Kenilworth, N.J., USA These presentations from Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) include “forward- looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Slide 3: Embedding Immunobiology Across Discovery Efforts
EMBEDDING IMMUNOBIOLOGY ACROSS DISCOVERY EFFORTS Neuro- • Immunology is linked to most science disease states Other Oncology • Unlocking new opportunities to address unmet needs in areas previously “undruggable” Metabolic Renal Immunology • Increased understanding of biology Disorders and importance
Slide 4: Delivering Our Mission Across Modalities
DELIVERING OUR MISSION ACROSS MODALITIES • Working across a number of modalities, which allows us to address new and complex biology • Complexity of biological targets is increasing • Therapeutic modalities expand the druggable universe Dr. Dean Li • Choice of modality defines addressable biology an
Slide 5: Over 150 Discovery & Early Development Programs Across Broad Set of Disease Areas
OVER 150 DISCOVERY & EARLY DEVELOPMENT PROGRAMS ACROSS BROAD SET OF DISEASE AREAS • Heart Failure • Checkpoint / Costimulatory • Vascular Disease • Innate Activation / • Complications of diabetes / Immunocytokines obesity • Tumor Intrinsic CRMO1 • Other • Myeloid and Stromal 15% Immuno- • Metabolism
Slide 6: New Discovery Hubs
NEW DISCOVERY HUBS • Unleashing the power of Merck LONDON Research Labs Studying diseases facing aging populations • Demonstrating keen scientific experience and insight • Maximizing the ecosystems of CAMBRIDGE the key scientific and SOUTH SAN Exploring emerging technology innovation hub cities FRAN
Slide 7: Merck's Discovery Strategy
MERCK’S DISCOVERY STRATEGY Human biology drives our approach to discovery Understanding of immuno-oncology provides new insights into the role of immunology across every other therapeutic area Accessing biology through whatever modality necessary Broad and diversified emerging pipeline of unique mol